OXT and Prader-Willi syndrome: In 2014, Einfeld et al. reported on a study of 30 individuals with PWS included in an 18-week double-blind, randomized, placebo-controlled trial with an intranasal use of oxytocin to examine its effect on physical, behavioral, and cognitive function.